Clinical Trials Directory

Trials / Completed

CompletedNCT01718600

Long-term Neurocognitive Sequelae of Subclinical Microembolization During Carotid Interventions

Status
Completed
Phase
Study type
Observational
Enrollment
207 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

Microembolization is commonly associated with carotid artery stenting (CAS), but our understanding of subclinical microembolization is superficial. Through collaborative effects of multidisciplinary team-experts, novel approaches, and longitudinal evaluations, we hope to better understand the clinical significance and long-term cognitive effects of microemboli. This proposal may change our current clinical practice by providing a better outcome measure for carotid interventions and improving outcomes of CAS procedures through risk factor stratification. Our central hypothesis is that development of subclinical microemboli is associated with decline in cognitive function following CAS and that the risk of development of microemboli themselves is associated with patient- and procedure-related factors. We hope that this prospective study will help to clarify these important issues in the era of rapidly evolving percutaneous interventions.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNeuropsychological testing

Timeline

Start date
2011-06-01
Primary completion
2018-04-01
Completion
2018-04-01
First posted
2012-10-31
Last updated
2022-08-29

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01718600. Inclusion in this directory is not an endorsement.

Long-term Neurocognitive Sequelae of Subclinical Microembolization During Carotid Interventions (NCT01718600) · Clinical Trials Directory